LFM
TMO icon

LGT Fund Management’s Thermo Fisher Scientific TMO Stock Holding History

LGT Fund Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Sell
500
-6,224
-93% -$2.99M 0.01% 226
2026
Q1 		$3.31M Sell
6,724
-200
-3% -$109K 0.14% 141
2025
Q4 		$4.04M Buy
6,924
+1,483
+27% +$839K 0.32% 77
2025
Q3 		$2.89M Sell
5,441
-2,201
-29% -$1.02M 0.23% 104
2025
Q2 		$3.1M Buy
7,642
+596
+8% +$249K 0.27% 90
2025
Q1 		$3.51M Sell
7,046
-2,988
-30% -$1.62M 0.32% 67
2024
Q4 		$5.22M Buy
10,034
+702
+8% +$386K 0.46% 55
2024
Q3 		$5.72M Sell
9,332
-380
-4% -$225K 0.59% 52
2024
Q2 		$5.37M Buy
9,712
+3,457
+55% +$1.98M 0.67% 44
2024
Q1 		$3.64M Sell
6,255
-455
-7% -$255K 1.52% 19
2023
Q4 		$3.58M Hold
6,710
– – 1.53% 16
2023
Q3 		$3.33M Sell
6,710
-345
-5% -$184K 1.62% 14
2023
Q2 		$3.68M Sell
7,055
-895
-11% -$483K 1.69% 14
2023
Q1 		$4.58M Sell
7,950
-2,350
-23% -$1.32M 1.95% 9
2022
Q4 		$5.67M Hold
10,300
– – 2.45% 8
2022
Q3 		$5.22M Sell
10,300
-3,446
-25% -$1.93M 2.45% 8
2022
Q2 		$7.47M Buy
13,746
+5,746
+72% +$3.16M 1.1% 20
2022
Q1 		$4.74M Hold
8,000
– – 0.63% 36
2021
Q4 		$5.34M Buy
+8,000
New +$4.99M 1.54% 20

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LGT Fund Management's TMO Position: Q2 2026 in Review

LGT Fund Management reduced its Thermo Fisher Scientific (TMO) stake by 93% in Q2 2026, selling an estimated $2.99M and leaving 500 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #226.

LGT Fund Management first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $7.47M in Q2 2022. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • LGT Fund Management held 500 shares of Thermo Fisher Scientific worth $251K as of Q2 2026.
  • LGT Fund Management sold 6,224 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.99M.
  • Thermo Fisher Scientific made up 0.01% of LGT Fund Management's portfolio in Q2 2026, its #226 holding.
  • LGT Fund Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • LGT Fund Management's Thermo Fisher Scientific position peaked at $7.47M in Q2 2022.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on LGT Fund Management's 13F filing for Q2 2026, filed 10 Aug 2026.